Department of Nephrology, Brookdale University Hospital Medical Center, Brooklyn, NY, USA.
Department of Pulmonary Critical Care, Brookdale University Hospital Medical Center, Brooklyn, NY, USA.
Am J Case Rep. 2021 Mar 24;22:e930135. doi: 10.12659/AJCR.930135.
BACKGROUND During the coronavirus disease 2019 (COVID-19) pandemic of 2020, varied presentations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been reported. The present report is of a case of hyponatremia and encephalopathy due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) as the main presentation of SARS-CoV-2 infection in a 55-year-old woman. CASE REPORT A 55-year-old woman with type II diabetes mellitus presented with confusion and slurring of speech, with a temperature of 38.5°C, heart rate of 120 bpm, blood pressure of 159/81 mmHg, and oxygen saturation of 98% on room air. She did not have edema on examination. Laboratory testing showed a low sodium level of 116 mEq/L (reference range, 135-145 mEq/L) with urine osmolarity of 364 mOsm/kg, urinary sodium of 69 mEq/L, urinary potassium of 15.6 mEq/L, and serum osmolarity of 251 mOsm/kg. The patient had normal serum thyroid-stimulating hormone and cortisol levels. A chest X-ray should no pulmonary infiltrates nor did a lumbar puncture reveal signs of infection. A real-time SARS-CoV-2 polymerase chain reaction assay was positive for COVID-19. Brain imaging with computed tomography was negative for acute infarct, intracranial hemorrhage, and mass effect. Based on findings from laboratory testing and physical examination, a diagnosis of SIADH was made. The patient was treated with 3% hypertonic saline, followed by salt tablets and fluid restriction, with improvement in her clinical symptoms and serum sodium level. CONCLUSIONS The present report is of a rare but previously reported association with SARS-CoV-2 infection. Encephalopathy and hyponatremia associated with SIADH without pneumonia or other symptoms of infection should be an indication for testing for SARS-CoV-2 infection.
在 2020 年的 2019 年冠状病毒病(COVID-19)大流行期间,报告了各种严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的表现。本报告介绍了一例 55 岁女性因 SARS-CoV-2 感染引起的抗利尿激素分泌不当综合征(SIADH)导致低钠血症和脑病的病例。
一名 55 岁女性,患有 2 型糖尿病,表现为意识混乱和言语不清,体温为 38.5°C,心率为 120 次/分,血压为 159/81mmHg,血氧饱和度为 98%,在室内空气下。她检查时没有水肿。实验室检查显示血清钠水平低至 116mEq/L(参考范围为 135-145mEq/L),尿渗透压为 364mOsm/kg,尿钠 69mEq/L,尿钾 15.6mEq/L,血清渗透压为 251mOsm/kg。患者血清促甲状腺激素和皮质醇水平正常。胸部 X 线片未见肺部浸润,腰椎穿刺也未显示感染迹象。实时 SARS-CoV-2 聚合酶链反应检测呈 COVID-19 阳性。脑成像计算机断层扫描未见急性梗死、颅内出血和肿块效应。根据实验室检查和体格检查结果,诊断为 SIADH。患者接受 3%高渗盐水治疗,随后服用盐片和限制液体摄入,临床症状和血清钠水平均有所改善。
本报告介绍了一种罕见但先前有报道的与 SARS-CoV-2 感染相关的情况。无肺炎或其他感染症状的 SIADH 相关脑病和低钠血症应作为检测 SARS-CoV-2 感染的指征。